Latest News - Dementia & Cognitive Disorders

Thursday, April 06, 2017 | Dementia & Cognitive Disorders

B. Smith and Husband Dan Gasby to Receive American Brain Foundation’s PLINA Award

B. Smith and her husband Dan Gasby are the 2017 recipients of the American Brain Foundation’s Public Leadership in Neurology Award (PLINA). Smith is a celebrity chef, restaurateur, supermodel, a…

Read the full story

Tuesday, March 28, 2017 | Dementia & Cognitive Disorders, Research and Publications

New Evidence Suggests Potential for Blood-Based Alzheimer’s Biomarker

Plasma neurofilament light (NFL) may represent a blood-based, non-invasive biomarker in Alzheimer’s disease (AD), according to new findings published in the JAMA Neurology (March 27, 2017). In a…

Read the full story

Wednesday, January 25, 2017 | Dementia & Cognitive Disorders, FDA Approval/Clearance, Product Launches and Updates

Memory Impairment Screening Tool Gains FDA Clearance

The FDA has granted 510(k) clearance to CANTAB Mobile (Cambridge Cognition), a sensitive screening tool for the detection clinically-relevant memory impairment in older adults at the point of care. CA…

Read the full story

Thursday, January 12, 2017 | Dementia & Cognitive Disorders, Research and Publications

High Levels of Aluminum Found in Brain Tissue of Individuals with Familial Alzheimer’s Disease

A British study has found extremely high levels of aluminum in the tissue of brains of individuals with familial Alzheimer’s disease. Using fluorescence microscopy to identify aluminum, investig…

Read the full story

Thursday, January 05, 2017 | Dementia & Cognitive Disorders, Phase 3/4 Trials, Research and Publications

Neuronix Reveals Data Suggesting Non-invasive TMS Device Improves Cognitive Performance in Alzheimer’s Disease

New findings suggest that an investigational device that combines transcranial magnetic stimulation (TMS) with cognitive training may improve cognitive performance in individuals with Alzheimer&r…

Read the full story

Wednesday, December 21, 2016 | Dementia & Cognitive Disorders, Research and Publications

Phase 2 Data Finds Pimavanserin Effective and Well Tolerated in Patients with Alzheimer’s Disease Psychosis

Phase 2 Data Finds Pimavanserin Effective and Well Tolerated in Patients with Alzheimer’s Disease Psychosis Acadia Pharmaceuticals has unveiled positive top-line results from its Phase 2 expl…

Read the full story

Tuesday, November 22, 2016 | Dementia & Cognitive Disorders, Research and Publications

Saliva Test May Detect Alzheimer’s Disease

A new saliva test developed by Aurin Bitech could serve as a diagnostic marker for Alzheimer’s disease, according to new findings published the Journal of Alzheimers Disease. The test is based o…

Read the full story

Thursday, October 27, 2016 | Dementia & Cognitive Disorders

Alzheimer’s Drug Discovery Foundation Launches Expanded Brain Health and Dementia Prevention Website

The Alzheimer’s Drug Discovery Foundation (ADDF) has relaunched CognitiveVitality.org, its brain health and dementia prevention website. Specifically, the site offers ratings on potential benefi…

Read the full story

Tuesday, October 25, 2016 | Dementia & Cognitive Disorders, Phase 3/4 Trials, Research and Publications

Tramiprosate Shows Gene-Dose Effect in Alzheimer’s Patients with APOE4

New phase 3 findings suggest that the investigational amyloid-targeted agent tramiprosate may particularly effective for patients with ε4 alleles of apolipoprotein E (APOE4), a genetic risk fa…

Read the full story